Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(29)
- Computing and Computational Sciences Directorate (39)
- Energy Science and Technology Directorate (229)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate
(138)
- User Facilities (28)
Researcher
- Edgar Lara-Curzio
- Ying Yang
- Adam Willoughby
- Bruce A Pint
- Eric Wolfe
- Rishi Pillai
- Steven J Zinkle
- Yanli Wang
- Yutai Kato
- Alice Perrin
- Ben Lamm
- Beth L Armstrong
- Bishnu Prasad Thapaliya
- Brandon Johnston
- Brian Sanders
- Charles Hawkins
- Christopher Ledford
- Frederic Vautard
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Jeff Foster
- Jerry Parks
- Jiheon Jun
- John F Cahill
- Josh Michener
- Liangyu Qian
- Marie Romedenne
- Meghan Lamm
- Michael Kirka
- Nidia Gallego
- Patxi Fernandez-Zelaia
- Paul Abraham
- Priyanshi Agrawal
- Ryan Dehoff
- Shajjad Chowdhury
- Tim Graening Seibert
- Tolga Aytug
- Vilmos Kertesz
- Weicheng Zhong
- Wei Tang
- Xiang Chen
- Xiaohan Yang
- Yan-Ru Lin
- Yang Liu
- Yong Chae Lim
- Zhili Feng

The first wall and blanket of a fusion energy reactor must maintain structural integrity and performance over long operational periods under neutron irradiation and minimize long-lived radioactive waste.

The technologies provide a coating method to produce corrosion resistant and electrically conductive coating layer on metallic bipolar plates for hydrogen fuel cell and hydrogen electrolyzer applications.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The technology provides a transformational approach to digitally manufacture structural alloys with co- optimized strength and environmental resistance

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.